Astarté 0

DRUG3 trials

Sponsors

Instituto Bernabeu S.L.

Conditions

Women undergoing ovarian stimulation for oocyte donation.low ovarian reserve according to Bologna criteria and carriers of androgen receptor polymorphism

Phase 3

Transdermal testosterone pretreatment in poor responders with androgen receptor polymorphism undergoing ICSI: A Randomized Clinical Investigation.

Not yet recruitingCTIS2024-510596-37-01

Instituto Bernabeu S.L.low ovarian reserve according to Bologna criteria and carriers of androgen receptor polymorphism

Target: 100Updated: 2025-10-06

Phase 4

Evaluation of the efficacy of micronized natural progesterone (Seidigestan®) vs GnRH antagonists (Astarté®) in the prevention of LH surge during controlled ovarian stimulation: a randomized clinical trial.

RecruitingCTIS2023-504188-18-00

Instituto Bernabeu S.L.Women undergoing ovarian stimulation for oocyte donation.

Start: 2023-11-08Target: 150Updated: 2023-05-09

Transdermal testosterone pretreatment in poor responders with androgen receptor polymorphism undergoing ICSI: A Randomized Clinical Investigation.

WithdrawnCTIS2024-510596-37-00

Instituto Bernabeu S.L.low ovarian reserve according to Bologna criteria and carriers of androgen receptor polymorphism

Target: 100Updated: 2024-04-29